TrademarkDir
QL BIOPHARM
DEAD

Serial Number

79395644

Owner

Beijing QL Biopharmaceutical Co., Ltd

Filing Date

Jan 5, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

QL BIOPHARM Trademark

Serial Number: 79395644

QL BIOPHARM is a trademark filed by Beijing QL Biopharmaceutical Co., Ltd on January 5, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Beijing QL Biopharmaceutical Co., Ltd

Room 101 (Changping Demonstration Park),

Entity Type: 03

Trademark Details

Filing Date

January 5, 2024

Registration Date

Not Registered

Goods & Services

Body fat monitors; catheters; drainage tubes for medical purposes; cannulae; needles for medical purposes; medical apparatus and instruments; surgical apparatus and instruments; hypodermic syringes; drug injection device; blood glucose measuring equipment.

Medicines for human purposes; drugs for medical purposes; pharmaceutical preparations; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; vitamin preparations; dietary fibre; bacteriological preparations for medical use; dietetic substances adapted for medical use; nutritional supplements.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 12, 2026 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Feb 26, 2026 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 26, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 18, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 3, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 3, 2025 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Feb 26, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 26, 2025 ABN2
ATTORNEY REVIEW COMPLETED
Sep 25, 2024 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Sep 20, 2024 CREV
REFUSAL PROCESSED BY IB
Sep 1, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 14, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 14, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 3, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 2, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 1, 2024 DOCK
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 8, 2024 CRCV
APPLICATION FILING RECEIPT MAILED
May 22, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 22, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 16, 2024 REPR

Related Trademarks